Effects of (±)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats

Robert T. Matthews, Thomas Champney, Gerald D. Frye

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Acute treatment with (±)3,4-methylenedioxymethamphetamine (MDMA) at high doses (10 and 30 mg/kg, IP), but not lower doses increased locomotor activity in male rats. MDMA did not consistently produce any other stereotyped behaviors at any dose. Dopamine (DA) turnover rate as estimated by the ratio of brain tissue levels of 3,4-dihydroxyphenylacetic acid (DOPAC) over DA was decreased in the striatum for up to two hours after acute treatment with 10 mg/kg of MDMA. DA turnover rate was inconsistently decreased in the olfactory tubercle and medial basal hypothalamus, and was unchanged in the medial prefrontal cortex and the substantia nigra/ventral tegmental area. Two hours after a 30 mg/kg injection of MDMA, DA turnover rate was decreased in all brain areas tested. MDMA and d-amphetamine partially reversed a haloperidol-induced elevation of striatal DOPAC levels. In contrast, the nonamphetamine stimulant, amfonelic acid, enhanced haloperidol's effect. In chloral hydrate-anesthesized rats, MDMA injected IV partially inhibited spontaneous firing rate of DA neurons in the substantia nigra (34% decrease at 4 mg/kg of MDMA). Seventeen days after subchronic MDMA treatment (10 or 20 mg/kg, IP, twice per day for four days), DA and DOPAC levels were unchaged in all brain areas tested as compared to levels in control rats. It is concluded that acute treatment with high but not low doses of MDMA has a weak amphetamine-like effect on nigrostriatal as well as mesolimbic/mesocortical and tuberoinfundibular DA neurons in rats. Repeated treatment with MDMA does not appear to be toxic to mesotelencephalic or tuberoinfundibular DA neurons.

Original languageEnglish
Pages (from-to)741-747
Number of pages7
JournalPharmacology, Biochemistry and Behavior
Volume33
Issue number4
DOIs
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Rats
Brain
Dopamine
Dopaminergic Neurons
Neurons
Substantia Nigra
Haloperidol
Rat control
Middle Hypothalamus
Chloral Hydrate
Stereotyped Behavior
Therapeutics
Corpus Striatum
3,4-Dihydroxyphenylacetic Acid
Dextroamphetamine
Ventral Tegmental Area
Acids
Poisons
Amphetamine

Keywords

  • Amfonelic acid
  • D-Amphetamine
  • DA neuron activity
  • DOPAC
  • DOPAC/DA ratio
  • Dopamine
  • Haloperidol
  • Locomotor activity
  • MDMA
  • Mesocortical/mesolimbic
  • Nigrostriatal
  • Tuberoinfundibular

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Effects of (±)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats. / Matthews, Robert T.; Champney, Thomas; Frye, Gerald D.

In: Pharmacology, Biochemistry and Behavior, Vol. 33, No. 4, 01.01.1989, p. 741-747.

Research output: Contribution to journalArticle

@article{b9f9da93cfd5476ea22fcaa039e9cff8,
title = "Effects of (±)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats",
abstract = "Acute treatment with (±)3,4-methylenedioxymethamphetamine (MDMA) at high doses (10 and 30 mg/kg, IP), but not lower doses increased locomotor activity in male rats. MDMA did not consistently produce any other stereotyped behaviors at any dose. Dopamine (DA) turnover rate as estimated by the ratio of brain tissue levels of 3,4-dihydroxyphenylacetic acid (DOPAC) over DA was decreased in the striatum for up to two hours after acute treatment with 10 mg/kg of MDMA. DA turnover rate was inconsistently decreased in the olfactory tubercle and medial basal hypothalamus, and was unchanged in the medial prefrontal cortex and the substantia nigra/ventral tegmental area. Two hours after a 30 mg/kg injection of MDMA, DA turnover rate was decreased in all brain areas tested. MDMA and d-amphetamine partially reversed a haloperidol-induced elevation of striatal DOPAC levels. In contrast, the nonamphetamine stimulant, amfonelic acid, enhanced haloperidol's effect. In chloral hydrate-anesthesized rats, MDMA injected IV partially inhibited spontaneous firing rate of DA neurons in the substantia nigra (34{\%} decrease at 4 mg/kg of MDMA). Seventeen days after subchronic MDMA treatment (10 or 20 mg/kg, IP, twice per day for four days), DA and DOPAC levels were unchaged in all brain areas tested as compared to levels in control rats. It is concluded that acute treatment with high but not low doses of MDMA has a weak amphetamine-like effect on nigrostriatal as well as mesolimbic/mesocortical and tuberoinfundibular DA neurons in rats. Repeated treatment with MDMA does not appear to be toxic to mesotelencephalic or tuberoinfundibular DA neurons.",
keywords = "Amfonelic acid, D-Amphetamine, DA neuron activity, DOPAC, DOPAC/DA ratio, Dopamine, Haloperidol, Locomotor activity, MDMA, Mesocortical/mesolimbic, Nigrostriatal, Tuberoinfundibular",
author = "Matthews, {Robert T.} and Thomas Champney and Frye, {Gerald D.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1016/0091-3057(89)90464-4",
language = "English",
volume = "33",
pages = "741--747",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Effects of (±)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats

AU - Matthews, Robert T.

AU - Champney, Thomas

AU - Frye, Gerald D.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Acute treatment with (±)3,4-methylenedioxymethamphetamine (MDMA) at high doses (10 and 30 mg/kg, IP), but not lower doses increased locomotor activity in male rats. MDMA did not consistently produce any other stereotyped behaviors at any dose. Dopamine (DA) turnover rate as estimated by the ratio of brain tissue levels of 3,4-dihydroxyphenylacetic acid (DOPAC) over DA was decreased in the striatum for up to two hours after acute treatment with 10 mg/kg of MDMA. DA turnover rate was inconsistently decreased in the olfactory tubercle and medial basal hypothalamus, and was unchanged in the medial prefrontal cortex and the substantia nigra/ventral tegmental area. Two hours after a 30 mg/kg injection of MDMA, DA turnover rate was decreased in all brain areas tested. MDMA and d-amphetamine partially reversed a haloperidol-induced elevation of striatal DOPAC levels. In contrast, the nonamphetamine stimulant, amfonelic acid, enhanced haloperidol's effect. In chloral hydrate-anesthesized rats, MDMA injected IV partially inhibited spontaneous firing rate of DA neurons in the substantia nigra (34% decrease at 4 mg/kg of MDMA). Seventeen days after subchronic MDMA treatment (10 or 20 mg/kg, IP, twice per day for four days), DA and DOPAC levels were unchaged in all brain areas tested as compared to levels in control rats. It is concluded that acute treatment with high but not low doses of MDMA has a weak amphetamine-like effect on nigrostriatal as well as mesolimbic/mesocortical and tuberoinfundibular DA neurons in rats. Repeated treatment with MDMA does not appear to be toxic to mesotelencephalic or tuberoinfundibular DA neurons.

AB - Acute treatment with (±)3,4-methylenedioxymethamphetamine (MDMA) at high doses (10 and 30 mg/kg, IP), but not lower doses increased locomotor activity in male rats. MDMA did not consistently produce any other stereotyped behaviors at any dose. Dopamine (DA) turnover rate as estimated by the ratio of brain tissue levels of 3,4-dihydroxyphenylacetic acid (DOPAC) over DA was decreased in the striatum for up to two hours after acute treatment with 10 mg/kg of MDMA. DA turnover rate was inconsistently decreased in the olfactory tubercle and medial basal hypothalamus, and was unchanged in the medial prefrontal cortex and the substantia nigra/ventral tegmental area. Two hours after a 30 mg/kg injection of MDMA, DA turnover rate was decreased in all brain areas tested. MDMA and d-amphetamine partially reversed a haloperidol-induced elevation of striatal DOPAC levels. In contrast, the nonamphetamine stimulant, amfonelic acid, enhanced haloperidol's effect. In chloral hydrate-anesthesized rats, MDMA injected IV partially inhibited spontaneous firing rate of DA neurons in the substantia nigra (34% decrease at 4 mg/kg of MDMA). Seventeen days after subchronic MDMA treatment (10 or 20 mg/kg, IP, twice per day for four days), DA and DOPAC levels were unchaged in all brain areas tested as compared to levels in control rats. It is concluded that acute treatment with high but not low doses of MDMA has a weak amphetamine-like effect on nigrostriatal as well as mesolimbic/mesocortical and tuberoinfundibular DA neurons in rats. Repeated treatment with MDMA does not appear to be toxic to mesotelencephalic or tuberoinfundibular DA neurons.

KW - Amfonelic acid

KW - D-Amphetamine

KW - DA neuron activity

KW - DOPAC

KW - DOPAC/DA ratio

KW - Dopamine

KW - Haloperidol

KW - Locomotor activity

KW - MDMA

KW - Mesocortical/mesolimbic

KW - Nigrostriatal

KW - Tuberoinfundibular

UR - http://www.scopus.com/inward/record.url?scp=0024471993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024471993&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(89)90464-4

DO - 10.1016/0091-3057(89)90464-4

M3 - Article

C2 - 2575758

AN - SCOPUS:0024471993

VL - 33

SP - 741

EP - 747

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 4

ER -